Serigne Lo (@serinelo) 's Twitter Profile
Serigne Lo

@serinelo

ID: 744709452863942656

calendar_today20-06-2016 01:52:24

13 Tweet

42 Followers

102 Following

Serigne Lo (@serinelo) 's Twitter Profile Photo

Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram ascopubs.org/doi/abs/10.120…

Professor Richard Scolyer AO (@profrascolyer) 's Twitter Profile Photo

Below is 1st of series of publictns from outstanding Melanoma Institute Australia visiting Dutch dermatologist scholar MaryAnn El Sharouni: Predicting recurrence in pts with sentinel node‐neg #melanoma: validation of EORTC nomogram using population‐based data bjssjournals.onlinelibrary.wiley.com/doi/full/10.10… Serigne Lo

Melanoma Institute Australia (@melanomaaus) 's Twitter Profile Photo

Congrats to Anne Cust , Serigne Lo and Alex Varey & their teams for bringing the MIA Melanoma Risk Calculators to realisation. Have you checked your melanoma risk? melanomarisk.org.au

Roger Olofsson Bagge (@olofssonbagge) 's Twitter Profile Photo

Serigne Lo: the man defining the new speciality of ā€œStatistical oncologyā€! ⁦⁩The man that creates all the magic for the colleagues ⁦Professor Georgina Long AO (Bluesky @gvlongphdmd), Alex van Akkooi and colleagues at ⁦Melanoma Institute Australia⁩ Glad to meet him at #ASCO22

Serigne Lo: the man defining the new speciality of ā€œStatistical oncologyā€! ⁦⁩The man that creates all the magic for the colleagues ⁦<a href="/ProfGLongMIA/">Professor Georgina Long AO (Bluesky @gvlongphdmd)</a>, Alex van Akkooi and colleagues at ⁦<a href="/MelanomaAus/">Melanoma Institute Australia</a>⁩ Glad to meet him at #ASCO22
Professor Georgina Long AO (Bluesky @gvlongphdmd) (@profglongmia) 's Twitter Profile Photo

Proud of MIA researcher @_graceattrill, lead author on this paper published in #JITC. A significant discovery by the MIA team in our quest to improve outcomes for immunotherapy-treated patients. James Wilmott #immunotherapy

Melanoma Institute Australia (@melanomaaus) 's Twitter Profile Photo

In a significant step for personalised cancer treatment, a new online #ImmunotherapyOutcomesPrediction tool developed by MIA will help determine if advanced melanoma patients will respond to #immunotherapy. InĆŖs Pires da Silva @amenzies9 7news.com.au/news/public-he…

Melanoma Institute Australia (@melanomaaus) 's Twitter Profile Photo

Today MIA launched a world-first online calculator, the #ImmunotherapyOutcomesPrediction tool, to predict an advanced melanoma patient’s response to immunotherapy. A vital advance in personalising cancer treatment. Gabriella Rogers shared the story on #9News. InĆŖs Pires da Silva @amenzies9

Melanoma Institute Australia (@melanomaaus) 's Twitter Profile Photo

MIA's new #ImmunotherapyOutcomesPrediction online calculator, allows oncologists to assess patient's response to immunotherapy & plan personalised treatment. Saving lives, & reducing physical, emotional & financial burden. Tom Hartley #7NEWS Sydney Health bit.ly/ImmunotherapyP…

Melanoma Institute Australia (@melanomaaus) 's Twitter Profile Photo

A/Prof Serigne Lo leads a team responsible for the design & analysis of clinical trials, and the development of tools that guide the treatment of melanoma patients. You can deep-dive into his life and research in our latest #LabLife blog > bit.ly/4dXZrjT #melanoma

JAMA Dermatology (@jamaderm) 's Twitter Profile Photo

Risk of melanoma-related death increased significantly for patients with primary tumors of 0.8 to 1.0 mm in thickness. ja.ma/41oINXq

Risk of melanoma-related death increased significantly for patients with primary tumors of 0.8 to 1.0 mm in thickness. ja.ma/41oINXq